JMJD5 Antikörper (AA 151-380) (HRP)
Kurzübersicht für JMJD5 Antikörper (AA 151-380) (HRP) (ABIN7157153)
Target
Alle JMJD5 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 151-380
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human JmjC domain-containing protein 5 protein (151-380AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- JMJD5 (Jumonji Domain Containing 5 (JMJD5))
-
Andere Bezeichnung
- KDM8
-
Hintergrund
-
Background: Histone demethylase required for G2/M phase cell cycle progression. Specifically demethylates dimethylated \\\'Lys-36\\\' (H3K36me2) of histone H3, an epigenetic repressive mark, thereby acting as a transcription activator. Regulates expression of CCNA1 (cyclin-A1), leading to regulate cancer cell proliferation.
Aliases: FLJ13798 antibody, JmjC domain-containing protein 5 antibody, JMJD5 antibody, JMJD5 protein antibody, jumonji domain containing 5 antibody, Jumonji domain-containing protein 5 antibody, KDM8_HUMAN antibody, Lysine (K) specific demethylase 8 antibody, Lysine-specific demethylase 8 antibody
-
UniProt
- Q8N371
-
Pathways
- Chromatin Binding
Target
-